FairoozKabbinavarMD

Clinical Trials

• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy Start of enrollment: 1999 Nov 01

  Completed

  Phase 2

• Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms Start of enrollment: 1999 Sep 01

  Terminated

  Phase 3

• Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2002 Oct 01

  Completed

  Phase 2

• Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF) Start of enrollment: 2003 Jun 01

  Completed

  Phase 1, Phase 2

• Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 01

  Withdrawn

  Phase 1, Phase 2

• Cetuximab in Treating Patients With Recurrent or Progressive Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2005 Mar 01
• Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) Start of enrollment: 2005 May 01

  Completed

  Phase 2

• Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2005 Sep 01

  Unknown status

  Phase 2

• Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia Start of enrollment: 2007 Dec 01

  Completed

  Phase 2

• Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma Start of enrollment: 2010 Oct 01

  Withdrawn

  Phase 2

• Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy Start of enrollment: 2013 Oct 01

  Terminated

  Phase 2

• Join now to see all